Apr 17, 2019 | By Thomas
French biotechnology firm Poietis has introduced the granting of a 3rd patent for its laser-assisted 3D bioprinting expertise.
“We have been the primary to discover the commercial potenfial of laser assisted bioprinting expertise in numerous purposes. The granting of this collection of European patents additional helps Poiefis’ place within the subject of 3D bio-printing,” acknowledged Fabien Guillemot, President and CEO of Poietis.
Primarily based on its experience in bioprinting applied sciences and specifically excessive decision laser bioprinting, Poietis has additionally developed the multimodal bioprinting platform NGB (Subsequent Technology Bioprinting). The NGB platform goals to present tissue engineers and researchers better freedom within the selection of biomaterials and hydrogels. Winner of the 2014 ILab Contest (French Nationwide Competitors for Revolutionary start-up Creation of the Ministry of Analysis, Creation-Growth class) and the 2016 Worldwide Innovation Contest, Poietis’ laser-assisted 3D bioprinting expertise us initially developed on the INSERM and Bordeaux College. The laser-assisted bioprinting expertise can place cells in 3D with extraordinarily excessive mobile decision (on the order of ten microns) and mobile viability (over 95%).
In 2015, BASF signed an settlement with Poietis to make use of their expertise for analysis and improvement functions. Each firms are taking a look at methods of making use of Poietis’ bioprinting expertise to BASF’s present processes in an effort to enhance the corporate’s pores and skin equal mannequin Mimeskin. Poietis has additionally partnered with Servier Laboratories to create 4D printed liver toxicity detection gadget.
Most just lately, the corporate has introduced its 4D bioprinting platform, an automatic robotic system to enhance the standardization of producing processes and the performance of organic tissues.
The newest patent issued by the European Patent Workplace, Patent No. EP3233499, is entitled “Laser printing technique and gadget for implementing stated technique.” It follows the 2017 Patent No. EP2542659 entitled “Bioprinting Station, meeting comprising such bioprinting station and bioprinting technique” which pertains to the variation of the printing patterns on substrates; and 2018 Patent No. EP3234102 entitled “Methodology for laser printing organic elements and gadget for implementing stated technique”, which covers the laser-assisted bioprinting and multimodal bioprinting processes in Europe.
“The grant of those patents strengthens Poietis’ mental property asset,” defined Bruno Brisson, Normal Supervisor and VP Enterprise Growth at Poietis. “It is usually extra safety of vital technological bricks which are built-in into the NGB-R, next-gen bioprinting methods that we commercialize now.”
Posted in 3D Printer Firm
Possibly you additionally like:
Credit score : Supply Hyperlink